At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Algovita Spinal Cord Stimulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Clinical Outcomes of Pulse Widths <500 µS And >1000 µS During a Temporary Spinal Cord Stimulation Trial
In Brief
A clinical study evaluating Algovita Spinal Cord Stimulation System for Spinal Cord Stimulation and 2 related conditions. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effect of pulse widths \<500 µS and \>1000 µS on clinical outcomes during a temporary SCS trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Stimulation, Pain, Back, Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedMay 2018
Primary CompletionMay 2018
TodayJul 2026
First PostedMay 16, 2018
Enrollment StartFeb 26, 2018
Primary CompletionMay 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.1 years ago
Interventions
Algovita Spinal Cord Stimulation Systemdevice
The Algovita™ SCS system is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain and leg pain.